8-11-14-eicosatrienoic-acid and Eye-Diseases

8-11-14-eicosatrienoic-acid has been researched along with Eye-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 8-11-14-eicosatrienoic-acid and Eye-Diseases

ArticleYear
Subchronic (13-week) oral toxicity study of dihomo-gamma-linolenic acid (DGLA) oil in rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2009, Volume: 47, Issue:6

    Dihomo-gamma-linolenic acid (DGLA) is one of the essential fatty acids, and has anti-inflammatory and anti-allergic effects. To assess the toxicity of a novel DGLA oil produced by the fungus Mortierella alpina, we examined it in the Ames test and in acute and subchronic oral toxicity tests in rats. In the Ames test, no mutagenicity was found up to 5000 microg/plate. The acute toxicity test revealed no toxicity related to DGLA oil at 10 g/kg. In the subchronic toxicity test, DGLA oil (500, 1000, and 2000 mg/kg) was orally administered. Water and soybean oil (2000 mg/kg) were used for the no-oil control and soybean oil control groups, respectively. There was no death in either sex. Because of administration of large amounts of oil, food consumption was low in the soybean oil control and the three test groups, which appeared to mildly decrease urinary excretion of Na, K, and Cl, as well as total serum protein, albumin, and blood urea nitrogen levels. There were no toxicological changes in body weight, food consumption, ophthalmological examination, urinalysis, hematological examination, blood biochemical examination, necropsy, organ weight, or histopathological examination. These findings show that the no-observed-adverse-effect level of the DGLA oil was 2000 mg/kg.

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Blood Cell Count; Blood Chemical Analysis; Body Weight; Eating; Eye Diseases; Female; Male; Mortierella; Mutagenicity Tests; Organ Size; Rats; Rats, Sprague-Dawley; Urinalysis

2009